Keywords: Starch; Extra-long chain of amylopectin; Molecular composition; Crystalline structure; Functional properties; Relationship analysis; AAC; apparent amylose content; AAG; Aspergillus niger amyloglucosidase; AC; amylose content; APS; amylopectin short branch
مقالات ISI (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ALL; acute lymphoblastic leukaemia; AML; acute myeloid leukaemia; APL; acute promyelocytic leukaemia; ASR; age standardised incidence rates; CI; confidence interval; CML; chronic myeloid leukaemia; ECP; Eastern Cape Province; HMs; haematological malignanc
Keywords: APL; Early hemorrhagic deaths; Tissue factor; Annexin II; ETosis;
Keywords: ADP; adenosine diphosphate; ATP; adenosine triphosphate; APL; acute promyelocytic leukemia; Del-1; developmental endothelial locus-1; ECM; extracellular matrix; EGF; endothelial growth factor; EVs; extracellular vesicles; FA; fatty acid; LDL; low density
Keywords: VTE; venous thromboembolism; HSCT; hematopoietic stem cell transplant; LMWH; low molecular weight heparin; IMIDs; immunomodulatory drugs; AML; acute myeloid leukemia; IQR; interquartile range; TAT; thrombin antithrombin; FVII; factor VII; FVIII; factor VI
Keywords: TS; thrombotic storm; CS; chondroitin sulfate; APS; antiphospholipid antibody syndrome; aPL; antiphospholipid antibodies; TM; thrombomodulin; PROC; protein C; PROS1; protein S; PLG; plasminogen; PLAT; plasminogen activator; WES; whole exome sequencing; CG
Keywords: Antiphospholipid syndrome; Direct oral anticoagulants; Antiphospholipid antibodies; Recurrent thrombosis; Triple positivity; Arterial thrombosis; APS; antiphospholipid syndrome; aPL; antiphospholipid antibodies; VKA; vitamin K antagonist; DOAC; direct ora
Keywords: 5-FU; 5-fluorouracil; AF; atrial fibrillation; ALK; anaplastic lymphoma kinase; APD; action potential duration; APL; acute promyelocytic leukemia; BCR-ABL; breakpoint cluster region-Abelson; BTK; Bruton tyrosine kinase; CD20; cluster of differentiation 20
Keywords: APL; allosterically potentiating ligand; AD; Alzheimer's disease; Aβ; amyloid-β; ALS; amyotrophic lateral sclerosis; BCCAs; bilateral common carotid arteries stenosis; CTX; cerebral cortex; DAB; diaminobenzidine; Drp1; dynamin-related protein 1; ECTX;
Keywords: Myasthenia gravis; Systemic lupus erythematosus; Acetylcholine receptor antibody; Antinuclear antibody; Antiphospholipid antibody; Thymectomy; AChR; Acetylcholine receptor; anti-AChR antibody; Anti-acetylcholine receptor antibody; ANA; Antinuclear antibod
Keywords: aPL; Antiphospholipid antibodies; ACR; American College of Rheumatology; ANA; Antinuclear antibodies; APS; Antiphospholipid syndrome; ARA; American Rheumatology Association; CAPS; Catastrophic antiphospholipid syndrome; HELLP syndrome; Haemolysis, elevate
Keywords: ADP/ATP; adenosine di/tri phosphate; ApL; antiphospholipid; BTG; beta-thrombomodulin; COX; cycloâoxygenase; CVD; cardiovascular disease; DAMP; damage-associated molecular patterns; EC; endothelial cells; ECM; extracellular matrix; ET-1; endothelin-1; HC
Keywords: Sciatic nerve crush; Curcumin; Oxidative stress; Myelin; ARE; Antioxidant responsive element; APL; Area per lipid; BW; Beam walking; CMAP; Compound muscle action potential; GST-P; Glutathione S-transferase P; HES; Haematoxylin-eosin-safran; HO-1; Heme-oxy
Keywords: AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; ADAM; a disintegrin and metalloproteinase enzymes; ALDH; aldehyde dehydrogenase; ABC; ATP - binding cassette; BWS; Beckwith-Wiedemann syndrome; BMP; bone morphogenetic proteins; CSC; cancer s
Keywords: Carbon fibers; Graphite fibers; Emerging precursors; Lignin; Thermally induced crystal conversion; Void formation; Turbostratic; Glass-like; Graphitic; Orientation degree; Orientation recovery mechanisms; Carbon fiber defects; Lattice disorder; AA; acryla
Keywords: Cake décor; Tool; Grip force; Hand tool; APDF; Amplitude Probability Distribution Function; APL; Abductor Pollicis Longus; ED; Extensor Digitorum; FDS; Flexor Digitorum Superficialis; MVC; Maximum Voluntary Contraction; RMS; Root Mean Square; RPE; Rate o
Keywords: aCL; anticardiolipin antibodies (aCL); Apl; anti-phospholipid antibodies; EDD; end-diastolic diameter; EF; ejection fraction; ESD; end-systolic diameter; FAC; Fractional Area shortening; FS; Fractional shortening; Hb; hemoglobin; IVS; interventricular sep
Keywords: TANs; tumor associated neutrophils; TENs; tumor entrained neutrophils; ROS; reactive oxygen species; NETs; neutrophils extracellular traps; ACEi; angiotensin-converting enzyme inhibitors; ATRA; all-trans-retinoic acid; APL; acute promyelocytic leukemia; D
Keywords: Vaccinations; Autoimmunity; Lymphoproliferation; Military personnel; Microarray analysis; Apoptotic self-epitopes; BCG; Bacillus Calmette-Guérin; CDC; Centers for Disease Control and Prevention; Td; tetanus/diphtheria; MMR; measles/mumps/rubella; HA; hep
Keywords: ABC transporters; ATP binding cassette transporters; ALD; adrenoleukodystrophy; APL; acute promyelocytic leukemia; APTEDB; extra-domain B-specific aptide; ATP; adenosine triphosphate; ATRA; all-trans retinoic acid; BBB; blood-brain-barrier; BCRP; breast c
Keywords: aβ2-GPI; anti-β2-glycoprotein I; ab-ab; anti-brain antibodies; anti-dsDNA; anti-double stranded DNA; ANA; antinuclear antibodies; aPL; antiphospholipid antibodies; APS; antiphospholipid syndrome; ADHD; attention deficit hyperactivity disorders; ASD; aut
Keywords: Arsenic trioxide; Silibinin; Chrysin; Glioblastoma; Sensitization; ABC; ATP-binding cassette; ATO; arsenic trioxide; APL; acute promyelocytic leukemia; BSO; L-buthionine sulfoximine; GSH; reduced glutathione; GSSG; oxidised glutathione; GSx; total glutath
Keywords: antiphospholipid antibodies; atherosclerosis; epidemiology; thrombophilia; vascular endothelium; warfarin; aCL; anticardiolipin antibody; aPL; antiphospholipid antibody; apoER2; apolipoprotein E receptor 2; APS; antiphospholipid syndrome; β2-GP1; β2-gly
Keywords: APL; area penggunaan lain (non-forest area); Bappenas; badan perencanaan pembangungan nasional (Ministry of National Development Plan); BAU; business as usual; CPO; crude palm oil; GHG; greenhouse gas; GoI; Government of Indonesia; Inpres; instruksi presi
Keywords: ALDH; aldehyde dehydrogenase; APL; acute promyelocytic leukemia; ATRA; all trans retinoic acid; BBB; blood-brain-barrier; b-FGF; basic fibroblast growth factor; BMP; bone morphogenetic protein; CSC; cancer stem cells; ECM; extracellular matrix; EGFR; epid
Keywords: DMPC; 1,2-dimyristoyl-sn-glycero-3-phosphocholine; Cp; specific heat capacity at constant pressure; Tm; phase transition temperature; DLA; diffusion limited aggregation; DLS; dynamic light scattering; DSC; differential scanning calorimetry; MD; molecular
Keywords: APL; alkylphospholipids; HePC; Hexadecylphosphocholine; POPC; 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine; DLPC; dilauroyl-sn-glycero-3-phosphocholine; DMPC; 1,2-dimyristoyl-sn-glycero-3-phosphocholine; DPPC; 1,2-dipalmitoyl-sn-glycero-3-phosphocholi
Keywords: Gastric Cancer; Gastritis; Secondary Prevention; Primary Prevention; Helicobacter pylori; APL; advanced neoplastic noninvasive lesion; CI; confidence interval; GC; gastric cancer; IEN; intraepithelial neoplasia;
Keywords: Moment arm; Muscle; Vector; Line of action; Joint axis; Forearm; APL; abductor pollicis longus; BB; biceps brachii; BRAR; brachioradialis; ECRL; extensor carpi radialis longus; ECU; extensor carpi ulnaris; FCR; flexor carpi radialis; FCU; flexor carpi uln
Keywords: APC; antigen presenting cells; ANCA; anti-neutrophil cytoplasmic antibody; AECA; anti-endothelial cell antibodies; APL; anti-phospholipid; APS; anti-phospholipid syndrome; BVAS; Birmingham Vasculitis Activity Score; CTD; connective tissue disease; DC; den
Keywords: aPCC; activated prothrombin complex concentrate; aPL; antiphospholipid; FIX; factor IX; FMD; flow-mediated dilatation; FV; factor V; FVIII; factor VIII; HA; hemophilia A; HB; hemophilia B; HIV; human immunodeficiency virus; IMT; intima-media thickness; MT
Keywords: AES; advanced encryption standard; AMI; advanced metering infrastructure; AMR; automatic meter reading; APL; application layer; BIPV; building-integrated photovoltaic; DRG; distributed renewable generation; FiT; feed-in-tariff; GPRS; general packet radio
Keywords: APS; the antiphospholipid syndrome; aPL; antiphospholipid antibodies; aCL; anti-cardiolipin antibodies; anti-β2GPI; anti-β2 glycoprotein I antibodies; LA; lupus anticoagulants; ERM; ezrin, radixin and moesin; anti-moesin Abs; anti-moesin antibodies; ant
Keywords: APL; Acquired partial lipodystrophy; CGL; Congenital generalized lipodystrophy; MPGN; Membranoproliferative glomerulonephritis; FPL; Familial partial lipodystrophy; TuLip; Turkish Lipodystrophy Study Group; WB MRI; Whole body magnetic resonance imaging; N
Keywords: Ab; antibody/antibodies; MBL; mannose binding lectin/s; Ag; antigen/s; FH; Factor H; FI; Factor I; MAC; membrane attack complex; mAb; monoclonal antibody/ies; TF; tissue factor; HF; hemorrhagic fever; APLS; anti-phospholipid syndrome; aPL; anti-phospholip
Keywords: AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; ATRA; all-trans retinoic acid; BHA; butylated hydroxyanisole; C/EBP; CCAAT/enhancer binding proteins; CREB; cyclic AMP response element-binding proteins; CSF; cerebrospinal fluid; DUOX; dual
Keywords: Lipid rafts; Signal transduction; IGF-I/PI3K/Akt signaling; Fas/CD95; CASMER; Cancer; APL; alkylphospholipid analogue; CASMER; cluster of apoptotic signaling molecule-enriched rafts; DED; death effector domain; DD; death domain; DISC; death-inducing signa
Keywords: ABL; Abelson; ALL; acute lymphocytic leukemia; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; BC; blast crisis; BCR; breakpoint cluster region; BMP; bone morphogenetic protein; CBP; CREB-binding protein; CDK; cyclin dependent kinase; CEBP
Keywords: 4-HPR; N-(4-hydroxyphenyl)retinamide; 5â²-UTR; 5â²-untranslated region; 9-cis-RA; 9-cis retinoic acid; 9cUAB30; (2E,4E,6Z,8E)-8-(3â²,4â²-dihydro-1â²(2'H)-naphthalen-1â²-ylidene)-3,7-dimethyl-2,4,6-octatrienoic acid; Acitretin; (2E,4E,6E,8E)-9-(4-met
Keywords: ADR; adverse drug reaction; AE; adverse event; AML; acute myeloid leukemia; ALL; acute lymphoblastic leukemia; APL; acute promyelocytic leukemia; APTT; activated partial thromboplastin time; AT; antithrombin; CLL; chronic lymphocytic leukemia; CML; chroni
Keywords: APS; Antiphospholipid syndrome; HC; Healthy controls; nonAPS-TC; NonAPS thrombosis controls; aPL; Antiphospholipid antibodies; SLE; Systemic lupus erythematosus; PAI; Plasminogen activator inhibitor; SEM; Scanning electron microscopy; MPs; Microparticles;
Keywords: AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; ASX; additional sex combs; BM; bone marrow; bZIP; leucine zipper; C/EBPα; CCAAT/enhancer binding protein α; CN-AML; normal karyotype-AML; CR; complete remissions; DFS; disease-free survival
Keywords: ALL; acute lymphoblastic leukemia; APL; acute promyelocytic leukemia; PS; phosphatidylserine; PCA; procoagulant activity; L-ASP; L-asparaginase; DNR; daunorubicin; MNCs; mononuclear cells; BSA; bovine serum albumin; PPP; platelet-poor plasma; Phosphatidyl
Keywords: CoCl2; cobalt chloride; AML; acute myeloid leukemia; HIF-1 α; hypoxia-inducible factor-1 α; CQ; chloroquine; LAMP1 and 2; lysosome-associated membrane proteins 1 and 2; APL; acute promyelocytic leukemia; ATRA; all-trans retinoic acid; ATO; arsenic triox
Keywords: GRIP1; glucocorticoid receptor-interacting protein 1; TIF2; translation initiation factor 2; SRC; steroid receptor coactivator; NR; nuclear receptor; AD; activation domain; CBP; CREB binding protein; APL; acute promyelocytic leukemia; RAR; retinoic acid r
Keywords: acute promyelocytic leukemia; all-trans retinoic acid; APL; ATRA; hemorrhage; intracranial hemorrhage; leukemia;
In silico and in vitro study of magnetic niosomes for gene delivery: The effect of ergosterol and cholesterol
Keywords: Abbreviation; Complete name; MD; Molecular dynamics; APL; Area per lipid; ST60/Chol; Span 60/Tween 60/Ergosterol; ST60/Ergo; Span 60/Tween 60/Cholesterol; M-NPD; Magnetic niosome-entrapped protamine-condensed DNA; M-NPD-Ergo; Ergo-containing magnetic nios
Long noncoding RNAs act as regulators of autophagy in cancer
Keywords: lncRNA; long noncoding RNA; miRNA; microRNA; EMT; epithelial-mesenchymal transition; Atg; autophagy-related gene; HOTAIR; HOX antisense intergenic RNA; HCC; hepatocellular carcinoma; HULC; highly upregulated liver cancer; MALAT1; metastasis-associated lun
LncRNA HOXA-AS2 and its molecular mechanisms in human cancer
Keywords: lncRNA; HOXA-AS2; Diagnosis; Therapeutic target; Prognosis; APL; Acute promyelocytic leukemia; ATRA; All trans retinoic acid; Bax; BCL2-Associated X; BC; Breast cancer; Bcl-2; B-cell lymphoma-2; c-Myc; MYC proto-oncogene; CRC; Colorectal cancer; DDIT3; DN
PML nuclear bodies, membrane-less domains acting as ROS sensors?
Keywords: AKT; AKT serine/threonine kinase; AMPK; AMP activated protein kinase; AML; acute myeloid leukemia; APL; acute promyelocytic leukemia; FOXO1; forkhead box O1; FAO; fatty acid oxidation; HIF1A; hypoxia inducible factor 1 alpha subunit; KEAP1; Kelch-like ery